Exparel liposomal
Active substance: bupivacaine
bupivacaine
Centralised EU authorisationActive
Marketing holder: Pacira Ireland Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 138 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b18-7992-a256-3f721e87f5d3,01a1208c-2cc5-76e8-b7a3-224fee97fb73,01a1208c-3235-73cf-be27-5f838bcae0b3,01a1208c-3bf1-701c-aadb-57367f601fcc,01a1208c-3bf3-722a-9932-82c5be51027a;count=111 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004586
- Registration status
- Active
- ATC code
- N01BB01
Sources
- product · EMA · EMEA/H/C/004586 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004586 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004586 · Verified 2026-10-09